超声乳化人工晶状体植入术治疗糖尿病患者白内障  

Clinical observation of phacoemulsification combined with intraocular lens implantation on diabetic cataract patients

作　　者：赵玲[1] 靳扬扬[1] 张妍霞[1] 李冬[1] 王应利[1] 樊容[1] 

机构地区：[1]北京煤炭总医院眼科,中国北京市100028

出　　处：《国际眼科杂志》2012年第6期1099-1100,共2页International Eye Science

摘　　要：目的:探讨超声乳化人工晶状体植入术治疗糖尿病患者白内障的疗效观察。方法:糖尿病患者白内障80例106眼,施行透明角膜切口白内障超声乳化及折叠式人工晶状体植入,观察手术并发症及术后视力、切口愈合情况。结果:所有患者手术顺利,均Ⅰ期植入晶状体在囊袋内。术后3mo,裸眼视力≤0.1者6眼(5.7%),0.2～0.5者28眼(26.4%),0.6～1.0者72眼(67.9%)。术后无感染,切口愈合良好。结论:超声乳化折叠人工晶状体植入术是治疗糖尿病患者白内障安全的、有效的方法。AIM：To discuss clinical therapeutic effectiveness of phacoemulsification and intraocular lens（IOL） implantation on diabetic cataract patients. METHODS：Totally 80 cases （106 eyes） of diabetic cataract patients underwent phacoemulsification and foldable IOL implantation through temporal transparent cornea incision.The postoperative complications, visual acuity and incision healing were observed. RESULTS：All operations were finished successfully with primary IOL implantation in capsule.3 months after operation the naked eyes＇ vision≤0.1 were in 6 eyes（5.7%）,0.2-0.5 in 28 eyes （26.4% ）, 0.6-1.0 in 72 eyes （67.9%）.There was no bleeding during operation and no infection after operation. CONCLUSION： It is safe and efficient to treat diabetic cataracts with phacoemulsification combined with foldable IOL implantation.

关 键 词：超声乳化 人工晶状体 糖尿病 白内障 

分 类 号：R779.66[医药卫生—眼科]